UHealth - University of Miami Health System

Jennifer J. Hu, Ph.D.

General Information

Jennifer J. Hu, Ph.D.

Contact

  • Office: 305-243-7796
  • Fax: 305-243-2997
  • .(JavaScript must be enabled to view this email address)

Languages

  • English

Roles

  • Associate Director, Division of Cancer Prevention and Control, Sylvester Comprehensive Cancer Center
  • Professor, Department of Biochemistry and Molecular Biology
  • Professor, Department of Public Health Sciences

CV

Research Interests

• Cancer Health Disparities
• DNA Repair in Cancer Risk and Treatment
• Genomics in Cancer Diagnosis and Prognosis
• Precision Cancer Therapies
• Targeted Cancer Intervention
 

Education

1996 M.S.
Georgetown University Medical School
1988 Ph.D.
UMDNJ-New Jersey Medical School
1983 M.S.
University of Louisiana
1981 B.S.
Fu-Jen Catholic University

Publications

Biography

Dr. Hu is a Professor in the Departments of Public Health Sciences, Biochemistry and Molecular Biology, and Human Genetics and Genomics. She also serves as the Associate Director for Prevention and Control and the Cancer Epidemiology and Prevention program leader at the Sylvester Comprehensive Cancer Center. She has training in basic, population, and clinical/translational sciences, which contributes to her unique capacity in developing and collaborating multidisciplinary research projects. She is the course director for Research Seminar, Molecular and Genetic Epidemiology and Cancer Epidemiology and Prevention. Her research program has been continuously funded for more than 20 years with peer-reviewed grants from NIH/NCI/ACS/DOD/FL since 1992. Her broad scientific expertise includes basic laboratory research in DNA damage/repair, molecular and genetic epidemiology, genomic and epigenomic prediction models of survival, chemoprevention, and cancer health disparities. With a strong commitment to collaboration, she serves as a co-investigator or co-author on a number of grants and publications. She also contributes to two large GWAS consortia of prostate and breast cancers in African Americans. Her current research program focuses on genomic and epigenomic prediction models of treatment response and clinical outcome to pave the way for precision medicine. With her diverse research background and strong commitment in training/education, she has successfully mentored many young scientists from different disciplines. She has served on more than 50 NIH/NCI/DOD study sections; became a regular member of the NCI subcommittee F for training grants in 2013 and the chair of the DOD prostate cancer disparity study section during 2011-2013.